A study that analyzed the correlation between tumor gene expression and patient survival on chemotherapy found that the top gene-drug interaction among patients with cervical squamous cell carcinoma and endocervical adenocarcinoma was that of C19orf57 and cisplatin [16]. The gene discussed is BRME1; the disease is cervical squamous cell carcinoma.